INGREDIENT COMPARISON
Tranexamic acid and alpha-arbutin both treat hyperpigmentation, melasma, and post-acne marks, but at different points in the melanin cascade. Tranexamic acid blocks the plasmin pathway and works best for melasma triggered by hormones, sun, or pregnancy. Alpha-arbutin is a glycosylated tyrosinase inhibitor: gentle, well-tolerated, and the everyday brightener. The pharmacist's pick depends on whether melasma is in play.
Last reviewed by BIOSAR Scientific Team, PharmD, Cosmetic Chemistry, Pharmacy practice on .
| Use case | Skin type | Tranexamic Acid | Alpha-Arbutin | Pairing rules |
|---|---|---|---|---|
| Melasma (hormonal pigmentation) | All — esp. III to V | 2% to 5% topicalTwice daily | 1% to 2% topicalTwice daily | Tranexamic acid is the first-line topical for melasma. Layer alpha-arbutin alongside for additive effect. |
| Post-acne marks (PIH) | All | Effective at 3% to 5%Twice daily | Effective at 1% to 2%Twice daily | Both pair cleanly with niacinamide and vitamin C. |
| Sun-spots and uneven tone | All | EffectiveTwice daily under SPF | Effective and gentlerTwice daily under SPF | Always layer broad-spectrum SPF; pigment work without sun protection plateaus. |
| Sensitive skin | Reactive | Tolerated topicallyTwice daily | Very well toleratedTwice daily | Alpha-arbutin is the gentler entry; tranexamic acid layers in once tolerance is established. |
| Pregnancy and breastfeeding | All | Topical use considered acceptable; oral form requires medical supervisionDiscuss with your clinician | Considered acceptable per Mother to BabyDaily | During pregnancy default to alpha-arbutin + niacinamide. Add tranexamic acid only on a clinician's advice. |
Choose tranexamic acid when melasma is the diagnosis or hormonal pigmentation dominates. It blocks the plasmin pathway, dampening the inflammation-driven melanin overproduction that fuels melasma. Topical 2% to 5% twice daily, over 8 to 12 weeks, with broad-spectrum SPF, is the standard plan. Pair with vitamin C in the morning and niacinamide twice daily for a layered protocol.
Choose alpha-arbutin for everyday tone-evening, post-acne marks, and sun-spots in any skin type. It is the gentler tyrosinase inhibitor, well-tolerated even on reactive skin. Use 1% to 2% twice daily for at least 8 weeks before judging the result. Stack with niacinamide and vitamin C; add tranexamic acid only when stubborn melasma resists the simpler protocol.
Tranexamic acid is a synthetic derivative of lysine. Topically, it inhibits the plasminogen-plasmin pathway in keratinocytes and reduces melanocyte activation in response to UV and inflammation. This is the only major topical that targets the inflammation-pigment axis directly, which is why it dominates the modern melasma protocol.
Alpha-arbutin is a glycosylated form of hydroquinone. The glucose protects the molecule and slows its hydrolysis, so the parent compound never reaches a cytotoxic dose. It binds tyrosinase reversibly, blocking the rate-limiting step of new melanin production at the source.
Kim et al. (Acta Derm Venereol 2017) showed 5% topical tranexamic acid matched 4% hydroquinone in a 12-week melasma trial, with fewer adverse events. Polnikorn (J Cosmet Laser Ther 2010) reported visible lightening of melasma after 12 weeks of 1% alpha-arbutin. The two studies underpin the modern combination protocol: pair tranexamic acid for the hormonal-melasma cascade with alpha-arbutin for everyday tyrosinase suppression.
Tranexamic acid is the lead active in the Serenvit Tranexamic Acid Serum. It pairs in the routine with niacinamide AM/PM and vitamin C in the morning.
Alpha-arbutin sits inside the Whitepurity Serum and the Serenvit Vitamin Complex Serum. It is the brightening base for everyday tone-evening, while the Serenvit tranexamic acid serum is reserved for stubborn melasma.
Treat tranexamic acid as the targeted melasma player. Treat alpha-arbutin as the everyday brightener that fits any routine. The most stubborn pigmentation cases use both, ideally with niacinamide as the base and vitamin C in the morning. Sunscreen is non-negotiable for any pigment-fading protocol; without it the result plateaus.
From the BIOSAR catalog
